pyrazolanthrone has been researched along with rolipram in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ayra, M; Calvo, JJ; Hernández-Hernández, A; Pérez, N; Sánchez-Bernal, C; Sánchez-Yagüe, J; Sarmiento, N | 1 |
| Calvo, JJ; Mangas, A; Pérez, N; Sánchez-Bernal, C; Sánchez-Yagüe, J; Sardina, JL; Sarmiento, N | 1 |
| Bai, L; Cai, GH; Guo, CH; Ma, W; Wang, X; Wu, HH; Wu, SX; Yang, J | 1 |
4 other study(ies) available for pyrazolanthrone and rolipram
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Changes in the expression and dynamics of SHP-1 and SHP-2 during cerulein-induced acute pancreatitis in rats.
Topics: Animals; Anthracenes; Ceruletide; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 3; Neutrophils; Pancreatitis; Phosphodiesterase 4 Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Rats, Wistar; Rolipram | 2008 |
Rolipram and SP600125 suppress the early increase in PTP1B expression during cerulein-induced pancreatitis in rats.
Topics: Animals; Anthracenes; Ceruletide; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutropenia; Pancreatitis; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Wistar; Rolipram; Vinblastine | 2010 |
The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Topics: Analgesics; Animals; Anthracenes; Astrocytes; Bone Neoplasms; Cancer Pain; Chemokine CCL2; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Female; Hyperalgesia; Inflammation Mediators; Injections, Spinal; JNK Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Spinal Cord; Up-Regulation | 2016 |